DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

about

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

P2860

Q48302949-659BFD59-2514-4335-A333-447F1972FF95

P2860

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

Item

http://www.wikidata.org/entity/Q38658334

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

@en

type

Item

label

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

@en

prefLabel

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

@en

P1476

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

@en

P2093

Daria O'Reilly

http://www.w3.org/2001/XMLSchema#string

Mary Alison Maloney

http://www.w3.org/2001/XMLSchema#string

Mitchel Levine

http://www.w3.org/2001/XMLSchema#string

P2860

Health technology reassessment: the art of the possible

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews.

Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: a systematic review.

Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis.

De-adoption and its 43 related terms: harmonizing low-value care terminology.

Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices.

FROM TALK TO ACTION: POLICY STAKEHOLDERS, APPROPRIATENESS, AND SELECTIVE DISINVESTMENT.

The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment

Guiding the process of health technology disinvestment.

P304

261-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462317000277

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lisa Schwartz

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28703087

http://www.w3.org/2001/XMLSchema#string

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

about

P2860

P2860

DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698